Items where Author / Artist / Editor is "Stordal, Britta K."

See full list of headings
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 23.

Article

Stordal, Britta K., Kalachand, Roshni and Hall, Neville (2018) Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer. Cochrane Database of Systematic Reviews (5). ISSN 1465-1858 (doi:10.1002/14651858.cd008766.pub2)

Busschots, Steven, O'Toole, Sharon, O'Leary, John J. and Stordal, Britta K. (2015) Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells. Experimental cell research, 336 (1). pp. 1-14. ISSN 0014-4827 (doi:10.1016/j.yexcr.2014.12.001)

McEvoy, Lynda M., O'Toole, Sharon A., Spillane, Cathy D., Martin, Cara M., Gallagher, Michael F., Stordal, Britta K., Blackshields, Gordon, Sheils, Orla and O'Leary, John J. (2015) Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer. BMC cancer, 15 . ISSN 1471-2407 (doi:10.1186/s12885-015-1539-8)

Busschots, Steven, O'Toole, Sharon, O'Leary, John J. and Stordal, Britta K. (2015) Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines. MethodsX, 2 . pp. 8-13. ISSN 2215-0161 (doi:10.1016/j.mex.2014.11.002)

Madden, Stephen F., Clarke, Colin, Stordal, Britta K., Carey, Mark S., Broaddus, Russell, Gallagher, William M., Crown, John, Mills, Gordon B. and Hennessy, Bryan T. (2014) OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets. Molecular Cancer, 13 (241). ISSN 1476-4598 (doi:10.1186/1476-4598-13-241)

D’Adhemar, Charles J., Spillane, Cathy D., Gallagher, Michael F., Bates, Mark, Costello, Katie M., Barry-O'Crowley, Jacqui, Haley, Kathryn, Kernan, Niamh, Murphy, Ciara, Smyth, Paul C., O'Byrne, Ken, Pennington, Stephen, Cooke, Aoife A., Ffrench, Brendan, Martin, Cara M., O'Donnell, Dearbhaile, Hennessy, Bryan T., Stordal, Britta K., Finn, Stephen, McCann, Amanda, Gleeson, Noreen, D'Arcy, Tom, Flood, Brian, O'Neill, Luke A. J., Sheils, Orla, O'Toole, Sharon and O'Leary, John J. (2014) The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer. PLoS One, 9 (6). ISSN 1932-6203 (doi:10.1371/journal.pone.0100816)

Lawlor, Denise, Martin, Patricia, Busschots, Steven, Thery, Julien, O'Leary, John J., Hennessy, Bryan T. and Stordal, Britta K. (2014) PARP inhibitors as P-glyoprotein substrates. Journal of Pharmaceutical Sciences, 103 (6). pp. 1913-1920. ISSN 1520-6017 (doi:10.1002/jps.23952)

McDermott, Martina, Eustace, Alex J., Busschots, Steven, Breen, Laura, Crown, John, Clynes, Martin, O'Donovan, Norma and Stordal, Britta K. (2014) In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies. Frontiers in oncology, 4 . ISSN 2234-943X

Doherty, Ben, Lawlor, Denise, Gillet, Jean-Pierre, Gottesman, Michael, O'Leary, John J. and Stordal, Britta K. (2014) Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells. Anticancer Research, 34 (1). pp. 503-507. ISSN 1791-7530

Stordal, Britta K., Timms, Kirsten, Farrelly, Angela, Gallagher, Danielle, Busschots, Steven, Renaud, Mickaël, Thery, Julien, Williams, Deborah, Potter, Jennifer, Tran, Thanh, Korpanty, Greg, Cremona, Mattia, Carey, Mark, Li, Jie, Li, Yang, Aslan, Ozlem, O'Leary, John J., Mills, Gordon B. and Hennessy, Bryan T. (2013) BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. Molecular Oncology, 7 (3). pp. 567-79. ISSN 1878-0261 (doi:10.1016/j.molonc.2012.12.007)

Stordal, Britta K., Hamon, Marion, McEneaney, Victoria, Roche, Sandra, Gillet, Jean-Pierre, O'Leary, John J., Gottesman, Michael and Clynes, Martin (2012) Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein. PLoS One, 7 (7). e40717. ISSN 1932-6203 (doi:10.1371/journal.pone.0040717)

Egan, Karl, Crowley, Darragh, Smyth, Paul, O'Toole, Sharon, Spillane, Cathy, Martin, Cara, Gallagher, Michael, Canney, Aoife, Norris, Lucy, Conlon, Niamh, McEvoy, Lynda, Ffrench, Brendan, Stordal, Britta K., Keegan, Helen, Finn, Stephen, McEneaney, Victoria, Laios, Alex, Ducrée, Jens, Dunne, Eimear, Smith, Leila, Berndt, Michael, Sheils, Orla, Kenny, Dermot and O'Leary, John J. (2011) Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PloS one, 6 (10). e26125. ISSN 1932-6203

Murphy, Mark and Stordal, Britta K. (2011) Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review. Drug Resistance Updates, 14 (3). pp. 177-90. ISSN 1368-7646 (doi:10.1016/j.drup.2011.02.004)

Stordal, Britta K. (2009) Citations, citations everywhere but did anyone read the paper? Colloids and surfaces. B, Biointerfaces, 72 (2). 312 -313. ISSN 1873-4367

Stordal, Britta K. and Davey, Ross A. (2009) ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair. Cancer Chemotherapy and Pharmacology, 63 (4). pp. 661-672. ISSN 0344-5704 (doi:10.1007/s00280-008-0783-x)

Stordal, Britta K. and Davey, Ross (2009) A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1. Current cancer drug targets, 9 (3). pp. 354-365. ISSN 1873-5576 (doi:10.2174/156800909788166592)

Stordal, Britta K. and Davey, Ross (2008) Platinum resistance needs the mythbusters. Toxicology letters, 180 (3). p. 230. ISSN 0378-4274 (doi:10.1016/j.toxlet.2008.07.003)

Stordal, Britta K. and Davey, Ross (2008) A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasome. IUBMB Life, 60 (3). pp. 180-184. ISSN 1521-6543 (doi:10.1002/iub.24)

Stordal, Britta K., Pavlakis, Nick and Davey, Ross (2007) A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship. Cancer Treatment Reviews, 33 (8). pp. 688-703. ISSN 0305-7372 (doi:10.1016/j.ctrv.2007.07.013)

Stordal, Britta K. and Davey, Mary (2007) Understanding cisplatin resistance using cellular models. IUBMB Life, 59 (11). pp. 696-9. ISSN 1521-6543 (doi:10.1080/15216540701636287)

Stordal, Britta K., Pavlakis, Nick and Davey, Ross A. (2007) Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treatment Reviews, 33 (4). pp. 347-357. ISSN 0305-7372 (doi:10.1016/j.ctrv.2007.01.009)

Stordal, Britta K., Peters, Greg and Davey, Ross A. (2006) Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance. Genes, Chromosomes & Cancer, 45 (12). pp. 1094-105. ISSN 1045-2257 (doi:10.1002/gcc.20373)

Stordal, Britta K., Davey, Mary W. and Davey, Ross A. (2006) Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Cancer Chemotherapy and Pharmacology, 58 (2). pp. 256-265. ISSN 0344-5704 (doi:10.1007/s00280-005-0148-7)

This list was generated on Fri Oct 18 05:20:18 2019 BST.